Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.132EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
K.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used